Literature DB >> 27188235

Prevalence of sacrococcygeal pilonidal disease in Turkey.

Kazim Duman1, Mustafa Gırgın2, Ali Harlak3.   

Abstract

BACKGROUND: Pilonidal sinus disease is frequently observed in the producing population; despite it not being a malignant disease, attention of clinicians to this disease has increased. Studies on this disease have not clearly revealed its prevalence. We aimed to detect its dispersion characteristics in our country.
MATERIALS AND METHODS: Our study was designed as a descriptive study involving a large number of patients. A total of 19,013 candidates, aged between 17 years and 28 years and coming from different regions of the country, who applied to be students or officials of the state's schools and institutions, were enrolled in the study. Examination was performed including the perineal region, the presence of any comorbid diseases was noted, and clinical types of pilonidal sinus disease were detected according to Tezel's classification and recorded.
RESULTS: Pilonidal sinus was detected in a total of 1258 (6.6%) candidates, of whom 72 (0.37%) were female and 1186 (6.23%) male. Our clinical experience showed that pilonidal cysts had a higher incidence in the Turkish population than in other populations, and it was especially increased in individuals of military age.
CONCLUSION: We believe that soldiers coming from different regions of Turkey and candidates applying for auxiliary staff positions provide a small sample group resembling a representation of the whole of Turkey.
Copyright © 2016. Published by Elsevier Taiwan.

Entities:  

Keywords:  Turkish population; dispersion characteristics; pilonidal sinus disease

Mesh:

Year:  2016        PMID: 27188235     DOI: 10.1016/j.asjsur.2016.04.001

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  8 in total

Review 1.  Karydakis procedure versus Limberg flap for treatment of pilonidal sinus: an updated meta-analysis of randomized controlled trials.

Authors:  Sameh Hany Emile; Sualeh Muslim Khan; Samer Hani Barsom; Steven D Wexner
Journal:  Int J Colorectal Dis       Date:  2021-04-10       Impact factor: 2.571

2.  Comparison of postoperative quality of life of Limberg flap and Karydakis flap in pilonidal sinus operations.

Authors:  Sabahattin Destek; Hüseyin Kazım Bektaşoğlu; Enver Kunduz; Merve Nil Akyüz
Journal:  Turk J Surg       Date:  2020-03-18

3.  Management of sacrococcygeal pilonidal sinus disease in children: A survey study in Turkey.

Authors:  Anar Gurbanov; Ergun Ergün; Gülnur Göllü; Ufuk Ateş
Journal:  Turk J Surg       Date:  2021-09-28

4.  The risk of recurrence of Pilonidal disease after surgical management.

Authors:  Feras M Almajid; Abdullah A Alabdrabalnabi; Khalifa Abdulaziz Almulhim
Journal:  Saudi Med J       Date:  2017-01       Impact factor: 1.484

5.  Topical polyphenol treatment of sacrococcygeal pilonidal sinus disease: use of ultrasonography to evaluate response to treatment - clinical case series study.

Authors:  Hasan Mete Aksoy; Berna Aksoy; Ezgi Ozkur; Emel Calikoglu
Journal:  Postepy Dermatol Alergol       Date:  2019-08-30       Impact factor: 1.837

6.  Impact of geography and surgical approach on recurrence in global pilonidal sinus disease.

Authors:  Dietrich Doll; Andriu Orlik; Katharina Maier; Peter Kauf; Marco Schmid; Maja Diekmann; Andreas P Vogt; Verena K Stauffer; Markus M Luedi
Journal:  Sci Rep       Date:  2019-10-22       Impact factor: 4.379

7.  Comparison between primary closure with Limberg Flap versus open procedure in treatment of pilonidal sinus, in terms of frequency of post-operative wound infection.

Authors:  Muhammad Sohail Jabbar; Mahwish Mahboob Bhutta; Nayyab Puri
Journal:  Pak J Med Sci       Date:  2018 Jan-Feb       Impact factor: 1.088

8.  Pilonidal sinus disease on the rise: a one-third incidence increase in inpatients in 13 years with substantial regional variation in Germany.

Authors:  Christina Oetzmann von Sochaczewski; Jan Gödeke
Journal:  Int J Colorectal Dis       Date:  2021-05-16       Impact factor: 2.571

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.